ArticleCommunications biology2026
CLEAR-IT, a framework for contrastive learning to capture the immune composition of tumor microenvironments.
Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- CLEAR-IT, a framework for contrastive learning to capture the immune composition of tumor microenvironments.Communications biology · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
Abstract
Accurate phenotyping of cells in the tumor microenvironment is essential for understanding cancer biology but typically requires precise cell segmentation, limiting scalability. Here, we introduce Contrastive Learning Enabled Accurate Registration of Immune and Tumor cells (CLEAR-IT), a self-supervised framework that learns cell-level features from multiplexed images using only cell locations. CLEAR-IT encoders achieve strong linear evaluation performance, improve substantially with hyperparameter optimization, and maintain high accuracy across imaging modalities and with up to 90% fewer labels. When substituted for handcrafted features in a state-of-the-art classifier, CLEAR-IT features yield higher performance, and their combination enables comparable accuracy with less than half of the labeled data otherwise required. The learned representations also support prognostic modeling: using annotations from a single patient, CLEAR-IT-based phenotyping identifies survival-associated tissue features that generalize across two cohorts and modalities. CLEAR-IT provides a segmentation-light, label-efficient approach for scalable cell phenotyping and enhances existing workflows in digital pathology and tumor microenvironment analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.